NURECA LTD.

NSE : NURECABSE : 543264ISIN CODE : INE0DSF01015Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE244.55-13.5 (-5.23 %)
PREV CLOSE ( ) 258.05
OPEN PRICE ( ) 260.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1781
TODAY'S LOW / HIGH ( )242.70 260.40
52 WK LOW / HIGH ( )198 343.6
NSE246.20-11.25 (-4.37 %)
PREV CLOSE( ) 257.45
OPEN PRICE ( ) 259.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 246.20 (1050)
VOLUME 24759
TODAY'S LOW / HIGH( ) 242.00 262.25
52 WK LOW / HIGH ( )203.62 343
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.